COSCIENS Biopharma Inc. (TSX:CSCI)

Canada · Delayed Price · Currency is CAD

2.300

-0.140 (-5.74%)

Mar 2, 2026, 11:41 AM EST

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Biopharmaceutical	1.10M	-	-	5.26M	3.65M
Biopharmaceutical Growth	-	-	-	44.03%	586.47%
Active Ingredient	8.49M	7.14M	14.57M	-	-
Active Ingredient Growth	18.89%	-50.98%	-	-	-
Total	9.59M	7.14M	14.57M	5.26M	3.65M
Total Growth	34.22%	-50.98%	177.03%	44.03%	586.47%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
United States	6.69M	3.42M	8.60M	-	-
United States Growth	95.87%	-60.28%	-	-	-
Germany	1.36M	3.56M	4.56M	-	-
Germany Growth	-61.83%	-21.92%	-	-	-
Colombia	300.00K	-	-	-	-
United Kingdom	976.00K	-	-	-	-
China	-	-	1.33M	-	-
Other	260.00K	164.00K	83.00K	-	19.00K
Other Growth	58.54%	97.59%	-	-	-57.78%
Switzerland	-	-	-	5.08M	905.00K
Switzerland Growth	-	-	-	460.77%	-
Ireland	-	-	-	-	73.00K
Ireland Growth	-	-	-	-	-1.35%
Denmark	-	-	-	185.00K	2.66M
Denmark Growth	-	-	-	-93.03%	542.86%
Total	9.59M	7.14M	14.57M	5.26M	3.65M
Total Growth	34.22%	-50.98%	177.03%	44.03%	586.47%

Source: S&P Global Market Intelligence.